HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mary-Ann Lindsay Selected Research

benthiocarb (Bolero)

7/2015Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mary-Ann Lindsay Research Topics

Disease

12Breast Neoplasms (Breast Cancer)
07/2015 - 04/2002
3Neoplasms (Cancer)
03/2011 - 08/2002
2Neutropenia
07/2015 - 10/2002
2Cardiotoxicity
10/2011 - 10/2002
2Febrile Neutropenia
10/2002 - 06/2002
1Neoplasm Metastasis (Metastasis)
07/2015
1Alopecia (Baldness)
07/2015
1Stomatitis
07/2015
1Heart Failure
10/2011
1Leukemia
10/2011
1Fatigue
04/2011
1Hypertension (High Blood Pressure)
04/2011
1Disease Progression
05/2004
1Infections
06/2002

Drug/Important Bio-Agent (IBA)

7Trastuzumab (Herceptin)FDA Link
07/2015 - 06/2002
7Docetaxel (Taxotere)FDA Link
01/2013 - 06/2002
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2013 - 06/2002
7AnthracyclinesIBA
01/2013 - 06/2002
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2013 - 06/2002
3Taxoids (Taxanes)IBA
10/2011 - 06/2002
2Paclitaxel (Taxol)FDA LinkGeneric
07/2015 - 04/2011
2Hormones (Hormone)IBA
07/2015 - 04/2011
2taxaneIBA
01/2013 - 04/2011
2Fluorouracil (Carac)FDA LinkGeneric
01/2013 - 08/2002
2Carboplatin (JM8)FDA LinkGeneric
10/2011 - 05/2004
2SaltsIBA
05/2004 - 06/2002
2PlatinumIBA
05/2004 - 06/2002
1Biological ProductsIBA
07/2015
1EverolimusFDA Link
07/2015
1benthiocarb (Bolero)IBA
07/2015
1Alkylating AgentsIBA
10/2011
1ErbB Receptors (EGF Receptor)IBA
10/2011
1Bevacizumab (Avastin)FDA Link
04/2011
1motesanib diphosphateIBA
04/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2011
1EnzymesIBA
03/2011
1Type II DNA Topoisomerases (Topoisomerase II)IBA
03/2011
1Cisplatin (Platino)FDA LinkGeneric
05/2004
1leridistimIBA
10/2002
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2002
1Monoclonal AntibodiesIBA
10/2002
1Filgrastim (Neupogen)FDA Link
10/2002
1Interleukin-3 Receptors (Interleukin 3 Receptor)IBA
10/2002
1myelopoietinIBA
10/2002
1Methotrexate (Mexate)FDA LinkGeneric
08/2002
1Proteins (Proteins, Gene)FDA Link
08/2002

Therapy/Procedure

6Drug Therapy (Chemotherapy)
07/2015 - 08/2002
5Therapeutics
07/2015 - 08/2002
2Combination Drug Therapy (Combination Chemotherapy)
01/2013 - 04/2002
1Neoadjuvant Therapy
04/2011
1Molecular Targeted Therapy
08/2002